Search Results - "Lammert, F"

How to improve success rates of endoscopic management for buried bumper syndrome by Casper, M, Lammert, F

“…Abstract Background Buried bumper syndrome (BBS) is a rare complication of percutaneous endoscopic gastrostomy. Complete BBS without visible parts of the inner…”
Get full text

Medication adherence among patients with chronic diseases: a survey-based study in pharmacies by Jüngst, C, Gräber, S, Simons, S, Wedemeyer, H, Lammert, F

“…Poor adherence to medication leads to worsening of the disease, increased mortality and substantial rise in health care costs. It was our aim to evaluate drug…”
Get full text

How to improve success rates of endoscopic management for buried bumper syndrome by Casper, M, Lammert, F

Get full text

Gastrointestinal: Next-generation DASE in extensive bile duct stone disease: Introducing "dilation-assisted cholangioscopic stone extraction" (DACSE) by Zimmer, V, Lammert, F

Get full text

Postprandial evolution in composition and characteristics of human duodenal fluids in different nutritional states by Clarysse, S, Tack, J, Lammert, F, Duchateau, G, Reppas, C, Augustijns, P

“…The purpose of this study was to assess the changes in duodenal composition in three nutritional states: fasted, fed, and fat-enriched fed state. Two…”
Get more information

Gemcitabine plus sorafenib versus gemcitabine alone in advanced biliary tract cancer: A double-blind placebo-controlled multicentre phase II AIO study with biomarker and serum programme by Moehler, M, Maderer, A, Schimanski, C, Kanzler, S, Denzer, U, Kolligs, F.T, Ebert, M.P, Distelrath, A, Geissler, M, Trojan, J, Schütz, M, Berie, L, Sauvigny, C, Lammert, F, Lohse, A, Dollinger, M.M, Lindig, U, Duerr, E.M, Lubomierski, N, Zimmermann, S, Wachtlin, D, Kaiser, A.-K, Schadmand-Fischer, S, Galle, P.R, Woerns, M

“…Abstract Background Since sorafenib has shown activity in different tumour types and gemcitabine regimens improved the outcome for biliary tract cancer (BTC)…”
Get full text

Treatment of refractory ascites with an automated low‐flow ascites pump in patients with cirrhosis by Stirnimann, G., Berg, T., Spahr, L., Zeuzem, S., McPherson, S., Lammert, F., Storni, F., Banz, V., Babatz, J., Vargas, V., Geier, A., Stallmach, A., Engelmann, C., Trepte, C., Capel, J., De Gottardi, A.

“…Summary Background Refractory ascites (RA) is a frequent complication of cirrhosis, requiring large volume paracentesis or placement of a transjugular…”
Get full text

Pre-endoscopy SARS-CoV-2 testing strategy during COVID-19 pandemic: the care must go on by Casper, M, Reichert, M C, Rissland, J, Smola, S, Lammert, F, Krawczyk, M

“…In response to the COVID-19 pandemic, endoscopic societies initially recommended reduction of endoscopic procedures. In particular non-urgent endoscopies…”
Get full text

Contribution of variant alleles of ABCB11 to susceptibility to intrahepatic cholestasis of pregnancy by Dixon, P H, van Mil, S W C, Chambers, J, Strautnieks, S, Thompson, R J, Lammert, F, Kubitz, R, Keitel, V, Glantz, A, Mattsson, L-A, Marschall, H-U, Molokhia, M, Moore, G E, Linton, K J, Williamson, C

“…Intrahepatic cholestasis of pregnancy (ICP) has a complex aetiology with a significant genetic component. ABCB11 encodes the bile salt export pump (BSEP);…”
Get more information

A letter on ABCB4 from Iceland: On the highway to liver disease by Lammert, F, Hochrath, K

“…Summary Large-scale whole-genome sequencing of the Icelandic population identified an association between several mutations of ABCB4 encoding the hepatobiliary…”
Get full text

O046 : Short-term vitamin d supplementation improves hepatic steatosis as quantified by controlled attenuation parameter (CAP) by Papapostoli, Lammert, F, Stokes, C.S

Get full text

CONKO-006: A randomised double-blinded phase IIb-study of additive therapy with gemcitabine + sorafenib/placebo in patients with R1 resection of pancreatic cancer – Final results by Sinn, M., Liersch, T., Riess, H., Gellert, K., Stübs, P., Waldschmidt, D., Lammert, F., Maschmeyer, G., Bechstein, W., Bitzer, M., Denzlinger, C., Hofheinz, R., Lindig, U., Ghadimi, M., Hinke, A., Striefler, J.K., Pelzer, U., Bischoff, S., Bahra, M., Oettle, H.

“…CONKO-006 was designed for patients with pancreatic adenocarcinoma with postsurgical R1 residual status to evaluate the efficacy and safety of the combination…”
Get full text

PNPLA3 p.I148M risk allele carriers might be at-risk of chemotherapy-associated steatohepatitis (CASH) by Casper, M, Zimmermann, S, Lammert, F, Krawczyk, M

Get full text

Effect of alcohol on the IL-6 mediated inflammatory response in a new mouse model of acute-on-chronic liver injury by Karatayli, E, Hall, R.A, Dooley, S, Lammert, F

Get full text

Chromocolonoscopy detects more adenomas than white light colonoscopy or narrow band imaging colonoscopy in hereditary nonpolyposis colorectal cancer screening by Hüneburg, R, Lammert, F, Rabe, C, Rahner, N, Kahl, P, Büttner, R, Propping, P, Sauerbruch, T, Lamberti, C

“…Individuals carrying germline mutations in one of the genes responsible for hereditary nonpolyposis colon cancer (HNPCC) have a lifetime risk of up to 80 % of…”
Get more information

The safety and efficacy of nasobiliary drainage in the treatment of refractory cholestatic pruritus: a multicentre European study by Hegade, V. S., Krawczyk, M., Kremer, A. E., Kuczka, J., Gaouar, F., Kuiper, E. M. M., Buuren, H. R., Lammert, F., Corpechot, C., Jones, D. E. J.

“…Summary Background Pruritus is a common symptom associated with cholestatic liver diseases. To date only small single centre case series have suggested…”
Get full text

Ribavirin long-term treatment for chronic hepatitis E virus infection in a liver transplant recipient by Casper, M, Reichert, MC, Rissland, J, Grünhage, F, Lammert, F

Get full text

Vitamin D Metabolic Chemotyping in Patients with Chronic Liver Diseases by Stokes, C.S, Müller, M, Volmer, D, Lammert, F

Get full text

Association of Controlled Attenuation Parameter (CAP) and HbA1c in Patients with Fatty Liver by Arslanow, A, Eid, A, Geisel, J, Lammert, F

Get full text

Toll-like receptor (TLR) 2 promoter and intron 2 polymorphisms are associated with increased risk for spontaneous bacterial peritonitis in liver cirrhosis by Nischalke, H.D, Berger, C, Aldenhoff, K, Thyssen, L, Gentemann, M, Grünhage, F, Lammert, F, Nattermann, J, Sauerbruch, T, Spengler, U, Appenrodt, B

“…Background & Aims Toll-like receptor (TLR) 2 and nucleotide-binding oligomerisation domain (NOD) 2 recognize distinct pathogen-associated molecular patterns…”
Get full text